These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21140149)

  • 21. Characterization of Anti-Bacterial Effect of the Two New Phages against Uropathogenic
    Slobodníková L; Markusková B; Kajsík M; Andrezál M; Straka M; Liptáková A; Drahovská H
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections.
    Nishikawa H; Yasuda M; Uchiyama J; Rashel M; Maeda Y; Takemura I; Sugihara S; Ujihara T; Shimizu Y; Shuin T; Matsuzaki S
    Arch Virol; 2008; 153(3):507-15. PubMed ID: 18188500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains.
    Zalewska-Piątek BM; Piątek RJ
    Acta Biochim Pol; 2019 May; 66(2):129-138. PubMed ID: 31136644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evaluation of a novel bacteriophage cocktail as a preventative for bovine coliform mastitis.
    Porter J; Anderson J; Carter L; Donjacour E; Paros M
    J Dairy Sci; 2016 Mar; 99(3):2053-2062. PubMed ID: 26774718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.
    Chegini Z; Khoshbayan A; Vesal S; Moradabadi A; Hashemi A; Shariati A
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):30. PubMed ID: 33902597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition.
    Galtier M; De Sordi L; Maura D; Arachchi H; Volant S; Dillies MA; Debarbieux L
    Environ Microbiol; 2016 Jul; 18(7):2237-45. PubMed ID: 26971586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-6/Stat3 signaling has an essential role in the host antimicrobial response to urinary tract infection.
    Ching CB; Gupta S; Li B; Cortado H; Mayne N; Jackson AR; McHugh KM; Becknell B
    Kidney Int; 2018 Jun; 93(6):1320-1329. PubMed ID: 29475562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage therapy: the Escherichia coli experience.
    Brüssow H
    Microbiology (Reading); 2005 Jul; 151(Pt 7):2133-2140. PubMed ID: 16000704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and identification of specific bacteriophage against enteropathogenic Escherichia coli (EPEC) and in vitro and in vivo characterization of bacteriophage.
    Vahedi A; Soltan Dallal MM; Douraghi M; Nikkhahi F; Rajabi Z; Yousefi M; Mousavi M
    FEMS Microbiol Lett; 2018 Aug; 365(16):. PubMed ID: 29945166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of three commercial bacteriophage cocktails against multidrug-resistant Escherichia coli and Proteus spp. strains of human and non-human origin.
    Bernasconi OJ; Donà V; Tinguely R; Endimiani A
    J Glob Antimicrob Resist; 2017 Mar; 8():179-185. PubMed ID: 28232228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The action of Escherichia coli CRISPR-Cas system on lytic bacteriophages with different lifestyles and development strategies.
    Strotskaya A; Savitskaya E; Metlitskaya A; Morozova N; Datsenko KA; Semenova E; Severinov K
    Nucleic Acids Res; 2017 Feb; 45(4):1946-1957. PubMed ID: 28130424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biofilm formation by Escherichia coli isolated from patients with urinary tract infections.
    Salo J; Sevander JJ; Tapiainen T; Ikäheimo I; Pokka T; Koskela M; Uhari M
    Clin Nephrol; 2009 May; 71(5):501-7. PubMed ID: 19473609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ibuprofen lacks direct antimicrobial properties for the treatment of urinary tract infection isolates.
    Whiteside SA; Dave S; Reid G; Burton JP
    J Med Microbiol; 2019 Aug; 68(8):1244-1252. PubMed ID: 31184571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex.
    Dufour N; Clermont O; La Combe B; Messika J; Dion S; Khanna V; Denamur E; Ricard JD; Debarbieux L;
    J Antimicrob Chemother; 2016 Nov; 71(11):3072-3080. PubMed ID: 27387322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteriophage-host interaction: from splendid isolation into a messy reality.
    Brüssow H
    Curr Opin Microbiol; 2013 Aug; 16(4):500-6. PubMed ID: 23725668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of a bacteriophage with broad host range, displaying potential in preventing bovine diarrhoea.
    Anand T; Vaid RK; Bera BCh; Barua S; Riyesh T; Virmani N; Yadav N; Malik P
    Virus Genes; 2015 Oct; 51(2):315-21. PubMed ID: 26174698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of sublethal concentrations of pefloxacin and ofloxacin on the adherence of Escherichia coli strains to human uroepithelial cells in vitro.
    Fera MT; Carbone M; Mastroeni P
    J Chemother; 1989 Jul; 1(4 Suppl):147-8. PubMed ID: 16312346
    [No Abstract]   [Full Text] [Related]  

  • 39. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of Escherichia coli-bacteriophage interactions by surfactants and antibiotics in vitro.
    Scanlan PD; Bischofberger AM; Hall AR
    FEMS Microbiol Ecol; 2017 Jan; 93(1):. PubMed ID: 27737900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.